Screener
Tandem Diabetes Care TNDM Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001438133-26-000125
| Assets | June 30, 2026 / (Unaudited) | December 31, 2025 / (Note 1) |
|---|---|---|
| Accrued expenses | 25,539 | 21,012 |
| Employee-related liabilities | 53,261 | 70,409 |
| Operating lease liabilities | 20,265 | 19,472 |
| Deferred revenue | 8,430 | 9,527 |
| Other current liabilities | 81,380 | 75,237 |
| Total current liabilities | 253,005 | 242,724 |
| Convertible senior notes, net - long-term | 602,577 | 310,036 |
| Operating lease liabilities - long-term | 116,411 | 114,967 |
Item 1. Financial Statements.
FAQ
- What is Tandem Diabetes Care's deferred revenue?
- Tandem Diabetes Care (TNDM) reported deferred revenue of $8.43M in Q2 2026.
- How has Tandem Diabetes Care's deferred revenue changed year-over-year?
- Tandem Diabetes Care's deferred revenue decreased by 19.8% year-over-year, from $10.52M to $8.43M.
- What is the long-term trend for Tandem Diabetes Care's deferred revenue?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's deferred revenue has grown at a 9.4% compound annual growth rate (CAGR), from $6.08M to $9.53M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about Tandem Diabetes Care's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude